The Effect of Mesenchymal Secretome Stem Cell Therapy toward Caspase-3 Expression in Pregnant Mice with Pristan-Induced Lupus Model

Febrian Andhika Adiyana, M Adrianes Bachnas, Sri Sulistyowati, Nutria Widya Purna Anggraini, Supriyadi Hari Respati


Background: Systemic lupus erythematosus (SLE) is one of the pregnancy complications which cause an increase in fetal and maternal com­p­lications which are mainly caused by pla­cen­tal damage due to chronic inflammation and apoptosis. The rate of apoptosis can be assessed by the high expression of caspase-3 which is the ma­jo­rexecutioner caspases of apoptosis. The use of Mesenchymal Secretome Stem Cell for SLE the­rapy has an anti-inflammatory and anti-apo­p­to­tic role. This study aimed to examine the effect of mesenchymal secretome stem cell therapy to­ward caspase-3 expression in pregnant mice with pris­tan-induced lupus model.

Subjects and Method: This study was a ran­do­mized controlled trial. This study was con­ducted at the Prodia ProStem Laboratory, La­bo­ra­tory of the Faculty of Veterinary Medicine of Airlangga University, and Anatomical Pathology Laboratory, Faculty of Medicine, Airlangga Uni­ver­sity. A total of 14 healthy BALB/C female mice strain aged 6-8 weeks, with a bodyweight of 20-30 grams, were divided into two groups, (1) 7 preg­nant mice who received pristan therapy only, and (2) 7 pregnant mice who received pristan the­rapy and mesenchymal secretome stem cell.

The dependent variable was the caspase-3 exp­res­sion. The independent variable was the ad­mi­ni­s­tration of mesenchymal secretome stem cell the­rapy. The caspase-3 expression was measured by an immunoreactive score. The data were ana­ly­zed using independent t-test.

Results: After giving mesenchymal secretome stem cell therapy, the mean of the caspase-3 exp­res­sion in the treatment group (Mean=1.86; SD­=­0.66) was lower than the control group (Me­an­=­3.­30; SD = 1.42), with p=0.031.

Conclusion: Mesenchymal secretome stem cell the­rapy is effective for reducing caspase-3 exp­res­sion in the placenta of pregnant mice with pris­tan-induced lupus model.

Keywords: Caspase-3 expression, lupus, placen­ta

Correspondence: Febrian Andhika Adiyana. Department of Obs­tet­rics and Gynecology, Faculty of Medicine, Uni­vesitas Sebelas Maret/Moewardi Surakarta, Indo­nesia. Email: Mobile: 081215897960.

Indonesian Journal of Medicine (2020), 05(03): 224-229

Full Text:



Dos Santos N, Silva RF, Pinto MPL, Da Silva EB, Tasat DR, Amaral A (2017). Active Caspase-3 Expression Levels as Bioindicator of Individual Radiosensitivity. Anais Da Academia Brasileira De Ciencias. 89(1): 649-659. doi: 10.1590/00-01-3765201720160697.

Drago D, Cossetti C, Iraci N, Gaude E, Musco G, Bachi A, Pluchino S (2013). The stem cell secretome and its role in brain repair. Biochimie. 95:2271-2285. doi: 10.1016/j.biochi.2013.06.020.

Figueroa FE, Carrion F, Villanueva S, Khoury M (2012). Mesenchymal stem cell treatment for autoimmune disease: a critical review. Biol Res. 45: 269-277. doi: 10.4067/S0716-97602012000-300008.

Harrell CR, Fellabaum C, Jovicic N, Djonov V, Arsenijevic N, Volarevic V (2019). Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome. Cells. 8(5):467.

Khurana R, Wolf RE (2017). Systemic Lupus Erythematosus and Pregnancy. Retrieved from https://Emedicine.Medscape.Com/Article/335055-Overview.

Lin L, Du L (2018). The Role of Secreted Factors in Stem Cells mediated Immune Regulation. Cell Immunol. 32-6: 24-32. doi: 10.1016/j.cellimm.2017.-07.010.

Ling N, Lawson E, Von Scheven, E (2018). Adverse Pregnancy Outcomes in Adolescents and Young Women with Systemic Lupus Erythematosus: A National Estimate. Pediatr Rheumatol Online J. 16: 26-31. doi: 10.1186/s12969-018-0242-0.

Nurudhin A, Kertia IN, Adnan ZA (2017). Effect of Secretome Stem Cells on Expres-sion Interleukin 10 and Interleukin 17 in Mice Lupus Model. Bangladesh j med sci. 16(3): 418-22. doi: 10.3329/bjms.v16i3.32862.

Ogishima D, Matsumoto T, Nakamura Y, Yoshida K, Kuwabara Y (2000). Placental Pathology in Systemic Lupus Erythematosus with Antiphospholipid Antibodies. Pathol Int. 50: 224-9. doi: 10.1046/j.14401827.2000.01026.x.

Pokrovskaya LA, Zubareva EV, Nadezhdin SV, Lysenko AS, Litovkina TL (2020). Biological Activity of Mesenchymal Stem Cells Secretome as A Basis for Cell-free Therapeutic Approach. Re-search Results in Pharmacology. 6(1): 57-68. doi: 10.3897/rrpharmacology.6.49413.

Prawirohardjo S (2014). Ilmu Kebidanan Sarwono Prawirohardjo. Jakarta. PT. Bina Pustaka Sarwono Prawirohardjo. ISBN: 9789798150258.

Sharp AN, Heazell AEP, Crocker IP, Mor G (2010). Placental apoptosis in health and disease. Am J Reprod Immunol. 64(3):159-169.

Su YJ, Cheng TT, Chen CJ, Chang WN, Tsai NW, Kung CT, Wang HC, et al. (2014). Investigation of the caspase-dependent mitochondrial apoptotic pathway in mononuclear cells of patients with systemic lupus erythematosus. J Transl Med. 12: 303. doi: 10.1186/s12967-014-0303-1.

Teixeira FG, Carvalho MM, Panchalingam KM, Rodrigues AJ, Mendes-Pinheiro B, Anjo S,Manadas B, Behie LA, Sousa N, Salgado AJ (2017). Impact of the sec-retome of human mesenchymal stem cells on brain structure and animal behavior in a rat model of Parkinson’s disease. Stem Cells Transl. Med. 6: 634-646. doi: 10.5966/sctm.2016-0071.

Vizoso FJ, Eiro N, Cid S, Schneider J, Perez-Fernandez R (2017). Mesenchymal stem cell secretome: Toward cell-free therapeutic strategies in regenerative medicine. Int J Mol Sci. 18: 1852. doi: 10.3390/ijms18091852.


  • There are currently no refbacks.